Pregnancy Clinical Trial
Official title:
Waiting Time. Wasting Time: A Randomized Control Trial to Investigate the Health Impacts of Improving the Quality of Antenatal Care in Mozambique
NCT number | NCT02938936 |
Other study ID # | 0344 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 1, 2016 |
Est. completion date | July 1, 2017 |
Verified date | April 2018 |
Source | Harvard School of Public Health |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Our study's principle purpose is to determine whether decreasing waiting time before being seen for antenatal care increases demand for and use of antenatal care services in Mozambique.
Status | Completed |
Enrollment | 597 |
Est. completion date | July 1, 2017 |
Est. primary completion date | July 1, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: Inclusion criteria for individual study participants enrolled after delivery: 1. Women who delivered at the health facility during the weeks of recruitment Inclusion criteria for women whose waiting time is measured: 1. Women at the health facility to seek care for antenatal care or another reproductive health service (anticipate total enrollment of 800 women) Inclusion criteria for the health care provider survey is that the provider 1. Have worked in the health facility for at least 6 months 2. The health care worker provides ANC as part of their routine duties (anticipate total enrollment of 4 health care workers) Exclusion Criteria: Exclusion criteria for individual study participants enrolled after delivery: 1. Women under 18 years of age will be excluded 2. Women whose babies die during labor or childbirth from the delivery exit interviews There are no exclusion criteria for the sample of women whose waiting time will be measured There are no exclusion criteria for the health care provider survey |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Harvard School of Public Health | London School of Economics and Political Science |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in percent of women completing at least 4 prenatal care visits before and after intervention | During most recent pregnancy, as reported in an exit survey conducted at discharge from delivery at baseline and six months after the start of the scheduling intervention | ||
Primary | Change in average waiting time before being seen for prenatal care before and after intervention | Measured for 4 weeks at baseline before the start of the intervention, and for 4 weeks, 3 months after the start of the intervention | ||
Secondary | Change in nurses satisfaction with their job (1-5 scale) | Measured before the start of the intervention, and 6 months after the start of the intervention | ||
Secondary | Change in proportion of key ANC services respondent reports receiving at most recent prenatal care visit, 9 possible services measured in exit survey at discharge from delivery. | 9 key services include: IPTP dose provided, measured by self-report Delivery plan discussed, measured by self-report Hemoglobin test measured by patient report of having had their blood drawn Recommendations for family planning and breast feeding provided, measured by self-report Detection of breech measured by report of the provider palpating the tummy Blood pressure Measurement of uterine height Urine test Recommendation for what to do in emergencies |
Measured at baseline and 6 months after the start of the intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Completed |
NCT02523755 -
Evaluation of Regional Distribution of Ventilation During Labor With or Without Epidural Analgesia
|
Phase 4 |